Outcomes of CMML patients undergoing allo‐HCT are significantly worse compared to MDS—a study of the CMWP of the EBMT

A Rovó, L Gras, B Piepenbroek… - American journal of …, 2024 - Wiley Online Library
Although CMML since long has been separated from MDS, many studies continue to
evaluate the outcomes of both diseases after hematopoietic cell transplantation (allo‐HCT) …
被引用次数：1 相关文章

Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS-a study of the CMWP of the EBMT.

A Rovó, L Gras, B Piepenbroek, N Kröger… - American Journal of …, 2023 - europepmc.org
Although CMML since long has been separated from MDS, many studies continue to
evaluate the outcomes of both diseases after hematopoietic cell transplantation (allo-HCT) …

Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS-a study of the CMWP of the EBMT.

A Rovó, L Gras, B Piepenbroek, N Kröger… - American Journal of …, 2023 - hal.utc.fr
Although CMML since long has been separated from MDS, many studies continue to
evaluate the outcomes of both diseases after hematopoietic cell transplantation (allo-HCT) …

Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS-a study of the CMWP of the EBMT.

A Rovó, L Gras, B Piepenbroek, N Kröger… - American Journal of …, 2023 - hal.u-pec.fr
Although CMML since long has been separated from MDS, many studies continue to
evaluate the outcomes of both diseases after hematopoietic cell transplantation (allo-HCT) …
[PDF] universiteitleiden.nl

[PDF][PDF] Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS—a study of the CMWP of the EBMT

HC Reinhardt, A Radujkovic, D Blaise, G Kobbe… - 2023 - scholarlypublications …
Although CMML since long has been separated from MDS, many studies continue to
evaluate the outcomes of both diseases after hematopoietic cell transplantation (allo-HCT) …

Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS-a study of the CMWP of the EBMT.

A Rovó, L Gras, B Piepenbroek, N Kröger… - American Journal of …, 2023 - hal.parisnanterre.fr
Although CMML since long has been separated from MDS, many studies continue to
evaluate the outcomes of both diseases after hematopoietic cell transplantation (allo-HCT) …

Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS-a study of the CMWP of the EBMT.

A Rovó, L Gras, B Piepenbroek, N Kröger… - American Journal of …, 2023 - hal.univ-lille.fr
Although CMML since long has been separated from MDS, many studies continue to
evaluate the outcomes of both diseases after hematopoietic cell transplantation (allo-HCT) …

Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS-a study of the CMWP of the EBMT.

A Rovó, L Gras, B Piepenbroek, N Kröger… - American Journal of …, 2023 - hal-ciheam.iamm.fr
Although CMML since long has been separated from MDS, many studies continue to
evaluate the outcomes of both diseases after hematopoietic cell transplantation (allo-HCT) …

Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS-a study of the CMWP of the EBMT

A Rovo, L Gras, B Piepenbroek… - American Journal …, 2023 - researchportal.helsinki.fi
Although CMML since long has been separated from MDS, many studies continue to
evaluate the outcomes of both diseases after hematopoietic cell transplantation (allo-HCT) …

Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS-a study of the CMWP of the EBMT.

A Rovó, L Gras, B Piepenbroek, N Kröger… - American Journal of …, 2023 - hal.insa-toulouse.fr
Although CMML since long has been separated from MDS, many studies continue to
evaluate the outcomes of both diseases after hematopoietic cell transplantation (allo-HCT) …